IntelliGenome receives Colombia's INVIMA approval for CRISPR-TB Blood Test: Houston, Texas Wednesday, July 1, 2026, 15:00 Hrs [IST] IntelliGenome, Inc., a molecular diagnostics co ...

More than a century after the first tuberculosis vaccine was introduced, the world is struggling to control one of its oldest diseases. Tuberculosis (TB) continues to kill more people annually than ...

IntelliGenome, Inc., a molecular diagnostics company advancing next-generation tuberculosis detection technologies, today announced that Colombia's National Institute for Food and Drug Surveillance ...

Maharashtra has reported 6,111 new tuberculosis (TB) cases within the first 35 days of the Centre’s 100-Day TB Mukt Bharat ...

Introduction People diagnosed with tuberculosis (TB) after death (postmortem) experience the ultimate diagnostic delay. We ...

Mumbai: Maharashtra has detected 6,111 new tuberculosis (TB) cases within the first 35 days of the Centre’s 100-day TB-Free ...

Tuberculosis (TB) in children remains a significant yet often under-recognized public health challenge. Despite global ...

Monocytes are central to innate and adaptive immunity, regulating tissue homeostasis and inflammation. However, data on their ...

Learn how aggressive neuroendocrine carcinoma disrupts daily life—and why rapid treatment, strong caregiver support, and navigation resources matter. In this episode, ‘Current Treatments and Biomarker ...

Cystic fibrosis (CF) is an inherited condition caused by a mutation in the CFTR gene, leading to thick, sticky mucus that can block airways and damage the lungs, digestive system, liver, and pancreas.